MTOR and prostate carcinoma: At the molecular level, succinylation of a specific protein, for example, CPT1A, causes succinylation of SP5 at K391, which activates the master signaling pathway PDPK1-AKT/mTOR and promotes proliferation and survival of prostate cancer cells[6,33,191].